Anti-BAFF & IL-17A Antibody (Tibulizumab)
Catalog No.
F1087
Anti-BAFF & IL-17A Antibody (Tibulizumab)
Featured Products
Tibulizumab (LY 3090106) is a tetravalent bispecific monoclonal antibody targeting B cell activating factor (BAFF) and IL-17A with Kd values of 60 pM and 14 pM, respectively. Tibulizumab can be used in the study of autoimmune diseases.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
201.44 kDa
Dry ice
1849636-24-3
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
LY3090106
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9Y275 & Q16552
Human
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human IL 17A mFC at 2 ug/mL can bind Anti-BAFF & IL-17A Reference Antibody (Tibulizumab)
BAFF & IL-17A
Please avoid freeze-thaw cycles.